Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Jade-1: its structure, regulation and functions in the renal cancer
1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou 221002, China 84 West Huai-hai Road, Xuzhou, Jiangsu, P.R. China. dspei@xzmc.edu.cn.
Abstract:
Jade-1 is originally identified by the yeast two-hybrid system as a protein partner of von Hippel-Lindau (pVHL) tumor suppressor, a well-known renal tumor suppressor. In cellular signaling pathways, many upstream Jade-1 regulators, such as pVHL, CK1α, PC1, and NPHP4, can control its activity by stabilization, phosphorylation, and nuclear translocation. Numerous downstream effectors, including β-catenin, AKT, p21, and Bcl-2, are well modulated by Jade-1, which mainly regulates cell proliferation and apoptosis. Jade-1 is also deemed to be a candidate of transcriptional co-activator associated with histone acetyltransferase (HAT) activity. This review focuses on the anticancer role of Jade-1 in clear cell renal carcinoma and the inhibitory effect of Jade-1 on cystic renal diseases. This review aims to provide a basis of disease prevention or therapy.
Insights
Jade-1 protein regulates cell proliferation and apoptosis, showing anticancer effects in clear cell renal carcinoma and potential for treating cystic renal diseases.
Area of Science:
- Molecular Biology
- Oncology
- Nephrology
Background:
- Jade-1 interacts with the von Hippel-Lindau (pVHL) tumor suppressor.
- Jade-1's activity is regulated by upstream factors like pVHL, CK1α, PC1, and NPHP4.
- Jade-1 modulates downstream effectors including β-catenin, AKT, p21, and Bcl-2, influencing cell proliferation and apoptosis.
Purpose of the Study:
- To review the anticancer role of Jade-1 in clear cell renal carcinoma.
- To examine the inhibitory effect of Jade-1 on cystic renal diseases.
- To provide a basis for disease prevention or therapy strategies involving Jade-1.
Main Methods:
- Literature review of studies on Jade-1 function and regulation.
- Analysis of Jade-1's interactions with upstream regulators and downstream effectors.
- Evaluation of Jade-1's role in clear cell renal carcinoma and cystic renal diseases.
Main Results:
- Jade-1 acts as a key regulator in cellular signaling pathways controlling proliferation and apoptosis.
- Jade-1 demonstrates significant anticancer activity against clear cell renal carcinoma.
- Jade-1 exhibits inhibitory effects on the development of cystic renal diseases.
Conclusions:
- Jade-1 is a crucial protein with therapeutic potential in renal cancer and cystic kidney diseases.
- Understanding Jade-1's regulatory mechanisms and downstream effects can inform novel treatment strategies.
- Further research into Jade-1 could lead to new avenues for disease prevention and management.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Hormonal Regulation
Abnormal Proliferation
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

